Biocure Technology Inc. (BICTF)
OTCMKTS · Delayed Price · Currency is USD
0.0100
+0.0086 (614.29%)
At close: May 14, 2025
Biocure Technology Market Cap
Biocure Technology has a market cap or net worth of $597.09 thousand as of February 12, 2026. Its market cap has decreased by -96.06% in one year.
Market Cap
597.09K
Enterprise Value
601.94K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since December 1, 2017, Biocure Technology's market cap has decreased from 31.22M to 597.09K, a decrease of -98.09%. That is a compound annual growth rate of -38.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 597.09K | -46.09% |
| Dec 30, 2025 | 1.11M | 917.12% |
| Dec 31, 2024 | 108.88K | -86.35% |
| Dec 19, 2022 | 797.48K | -92.64% |
| Dec 30, 2021 | 10.84M | -49.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EV Biologics | 840.53K |
| Altamira Therapeutics | 718.01K |
| Aibotics | 717.45K |
| SQZ Biotechnologies Company | 707.79K |
| Sorrento Therapeutics | 706.83K |
| Bio-Path Holdings | 609.98K |
| Helix BioMedix | 606.71K |
| Innovation Pharmaceuticals | 528.77K |